Abide Therapeutics in the News
Justin Cisar (Principal Scientist, Chemistry) presents "Discovery of ABX-1431: A Potent and Selective MGLL Inhibitor for Clinical Development" at the 21st Annual MedChem Symposium
Date & Time: July 20th, 2018; 2:05 p.m PT
Location: San Diego, CA
Media Contact
Patty Pilon
Abide Therapeutics
Tel: +1 619.244.2679
patty@abidetx.com